| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. While MSSA does not set or negotiate drug prices, we engage with regulators, policymakers, and advisory bodies to highlight the real-world impact of pricing and access decisions on people living with MS, particularly in a South African and broader African context. | Neurologisk
> Multipel skleros | Regulatoriskt partnerskap
> Arbeta med tillsynsmyndigheter | 5 000 | Regional | Regularly | 119035905477 |
| We are founder members of the SA [South Africa] NCD [Non-Communicable Disease] Alliance. | Endokrin
> Diabetes och hypertoni | Regulatoriskt partnerskap
> Med andra hälso- och sjukvårdsförespråkare | 10 000 | National | Sometimes | 119045009637 |
| We are one of three founding members of the South African Non-Communicable Disease Association. | Endokrin
> Diabetes och hypertoni | Regulatoriskt partnerskap
> Med andra hälso- och sjukvårdsförespråkare | 10 000 | National | Sometimes | 119051187994 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS [Multiple Sclerosis] treatments and by contributing the patient voice to policy, access, and reimbursement discussions. | Neurologisk
> Multipel skleros | Påverka politik och lagstiftning
> Påverka hälso- och sjukvårdspolitik och lagstiftning | 5 000 | Regional | Regularly | 119035905477 |
| CANSA [Cancer Association of South Africa] engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. | Cancer
> Cancer: de flesta typer | Påverka politik och lagstiftning
> Påverka hälso- och sjukvårdspolitik och lagstiftning | 10 000 | National | Regularly | 119044111428 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | Cancer
> Cancer: de flesta typer | Påverka politik och lagstiftning
> Delta i offentliga utfrågningar och samråd | 10 000 | National | Regularly | 119044111428 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS [Multiple Sclerosis] treatments and by contributing the patient voice to policy, access, and reimbursement discussions. | Neurologisk
> Multipel skleros | Påverkansarbete för prissättning och prisvärdhet
> Förespråka rättvisa läkemedelspriser | 5 000 | Regional | Regularly | 119035905477 |
| We often have to advocate for patients drug pricing, treatment baskets, and lists. | Reumatisk
> Axial spondylartrit | Påverkansarbete för prissättning och prisvärdhet
> Förespråka rättvisa läkemedelspriser | Over 100,000 | National | Regularly | 119051166861 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | Cancer
> Cancer: de flesta typer | Påverkansarbete för prissättning och prisvärdhet
> Delta i förhandlingar med prisgranskningsnämnden | 10 000 | National | Regularly | 119044111428 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | Cancer
> Cancer: de flesta typer | Påverkansarbete för prissättning och prisvärdhet
> Förespråkar inkludering av produkten i ersättningslistor/nationella läkemedelsförteckningar | 10 000 | National | Regularly | 119044111428 |
| We often have to advocate for patients drug pricing, treatment baskets, and lists. | Reumatisk
> Axial spondylartrit | Påverkansarbete för prissättning och prisvärdhet
> Förespråkar inkludering av produkten i ersättningslistor/nationella läkemedelsförteckningar | Over 100,000 | National | Regularly | 119051166861 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS [Multiple Sclerosis] treatments and by contributing the patient voice to policy, access, and reimbursement discussions. | Neurologisk
> Multipel skleros | Förbättra åtkomstvägar
> Underlätta rättvis tillgång till läkemedel/hälso- och sjukvård | 5 000 | Regional | Regularly | 119035905477 |
| CANSA [Cancer Association of South Africa] engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. | Cancer
> Cancer: de flesta typer | Förbättra åtkomstvägar
> Underlätta rättvis tillgång till läkemedel/hälso- och sjukvård | 10 000 | National | Regularly | 119044111428 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | Cancer
> Cancer: de flesta typer | Evidensbaserat patientinput
> Använd patientinsikter för att informera beslut | 10 000 | National | Regularly | 119044111428 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. While MSSA does not set or negotiate drug prices, we engage with regulators, policymakers, and advisory bodies to highlight the real-world impact of pricing and access decisions on people living with MS, particularly in a South African and broader African context. | Neurologisk
> Multipel skleros | Evidensbaserat patientinput
> Tillhandahåll verkliga bevis (RWE) till tillsynsmyndigheter | 5 000 | Regional | Regularly | 119035905477 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. Our input is informed by lived experience, patient-reported challenges, and international collaboration through global MS networks, ensuring that patient needs, equity, and sustainability are considered in decision-making processes. | Neurologisk
> Multipel skleros | Evidensbaserat patientinput
> Utnyttja patientberättelser och narrativ från levd erfarenhet | 5 000 | Regional | Regularly | 119035905477 |
| Have engaged the Department of Health. | Sällsynt
> Sällsynta sjukdomar: immunologiska | Institutionell styrning
> Se till att det finns representation inom statliga rådgivande organ | 100 | International | Rarely | 119036013383 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. While MSSA does not set or negotiate drug prices, we engage with regulators, policymakers, and advisory bodies to highlight the real-world impact of pricing and access decisions on people living with MS, particularly in a South African and broader African context. | Neurologisk
> Multipel skleros | Institutionell styrning
> Arbeta effektivt inom nätverk med flera intressenter | 5 000 | Regional | Regularly | 119035905477 |
| We are founder members of the SA [South Africa] NCD [Non-Communicable Disease] Alliance. | Endokrin
> Diabetes och hypertoni | Institutionell styrning
> Upprätthåll formell status som allmännyttig eller välgörenhetsorganisation | 10 000 | National | Sometimes | 119045009637 |